KARA COOPER-GILMER: Open Payments
NPI 1437387354 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53,311 in 198 payments from 28 companies in 2025. Trend: 2023 $21,906 · 2024 $20,982 · 2025 $53,311
Speaker / faculty: $40,775Travel & lodging: $9,047Food & beverage: $3,489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 103 | $51,222 |
| Novartis Pharmaceuticals Corporation | 13 | $279 |
| Teva Pharmaceuticals USA, Inc. | 15 | $253 |
| ACADIA Pharmaceuticals Inc | 7 | $166 |
| Alexion Pharmaceuticals, Inc. | 5 | $146 |
| ARGENX US, INC. | 4 | $132 |
| Genentech USA, Inc. | 5 | $117 |
| EMD Serono, Inc. | 5 | $110 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| Lilly USA, LLC | 6 | $106 |
Products named: QULIPTA, UBRELVY, KESIMPTA, AUSTEDO XR, NUPLAZID, ULTOMIRIS, VYVGART HYTRULO, INGREZZA.
Industry payments across SC — which companies pay providers there.
